Fujiwara Yoshiyuki, Taniguchi Hirokazu, Kimura Yutaka, Takiguchi Shuji, Yasuda Takushi, Yano Masahiko, Monden Morito
Dept. of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University.
Gan To Kagaku Ryoho. 2003 Oct;30(11):1614-7.
Forty-eight patients with serosa-invaded advanced gastric cancer were administered to pre-operative intra-peritoneal chemotherapy to prevent peritoneal recurrence. There were no severe adverse effects from the intra-peritoneal chemotherapy. Of these patients, 2 showed malignant ileus shortly after intra-peritoneal chemotherapy and gastrectomy, and needed laparotomy because of dilatation of duodenum stump and liver dysfunction. The intestines and mesothelium showed diffuse thickness and hardness. We report the clinicopathological features of these cases and therapeutic limitation of intra-peritoneal chemotherapy.
48例浆膜侵犯型进展期胃癌患者接受术前腹腔内化疗以预防腹膜复发。腹腔内化疗未出现严重不良反应。在这些患者中,2例在腹腔内化疗和胃切除术后不久出现恶性肠梗阻,因十二指肠残端扩张和肝功能障碍而需要剖腹手术。肠道和间皮显示弥漫性增厚和变硬。我们报告这些病例的临床病理特征及腹腔内化疗的治疗局限性。